Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit

Genaxx1Step Covid-19 direct RT-qPCR kit


Order number: M3164.0000

Shipping: shipped on wet ice, store at -20°C

Ready to ship today,
Delivery time 1-3 workdays

€55.00 *

pack size:

Please select the favoured pack size.

The Genaxx1Step one-step RT-qPCR SARS-CoV-2 Probe Kit contains our... more
Product information "Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit"

The Genaxx1Step one-step RT-qPCR SARS-CoV-2 Probe Kit contains our innovative HotScriptase RT which is an extremely thermo- and inhibitor stable DNA polymerase with reverse transcriptase activity which does not need purified RNA for transcription and amplification. The eluate of a swab is enough for direct RT-PCR. The Genaxxonkit is basically comparable to that of DiaSorin (Lilaison® MDX), but can be used on any real-time PCR device.
The HotScriptase polymerase facilitates an “OneStep” RT-PCRs directly from RNA templates, as reverse transcription takes place simultaneously with DNA amplification during the cycled PCR elongation step. Besides the very convenient protocol this allows reverse transcription reactions at higher temperatures, thus minimizing the problems encountered with strong secondary structures in RNA, or strong tertiary structures as in double strand RNA viruses that melt at elevated temperatures.
The assay is based on the CDC-approved EUA SARS-CoV2 primer/probes sets. In accordance with the aforementioned publication, N1-assay was supplemented with a high-melting primer R2 to improve assay performance with Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit.

Intended Usage
This document describes the use of real-time RT-PCR assays for the in vitro qualitative detection of SARS-CoV-2 Corona virus nucleocapsid fragment target N1 and the control target RNASeP according to the US Centers for Disease Control and Prevention (CDC), which published a protocol for the detection of the 2019-Novel Coronavirus (2019-nCoV). The 2019-nCoV primer and probe sets are designed for the specific detection of 2019-nCoV.

Genaxx1Step RT-qPCR SARS-CoV-2 Probe Assay Kit Detection system
Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit is a real-time RT-PCR based detection system for the 2019 Wuhan coronavirus (2019-nCoV). 2019-nCoV is considered a novel human coronavirus that is genetically distinct from the common human coronaviruses (229E, NL63, OC43, HKU1), which cause seasonal acute respiratory illness. It is also genetically distinct from the two newer human coronaviruses, MERS-CoV and SARS-CoV.

Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit detects the presence of the nucleocapsid fragment sequences N1 of 2019-nCoV / SARS-CoV-2 and the control target RNASeP even without prior RNA extraction.

NOTE: Always include positive and negative controls in your experiment to validate your results.

More products around "Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit"
Our comment on "Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit"
2-time RT-qPCR master mix no RNA extraction neede before RT-qPCR
Specificaitons: 2-time RT-qPCR master mix M3164.0100 for 100 x 50µL RT-qPCR reactions... more
 

Technical Data:

Specificaitons:
2-time RT-qPCR master mix

M3164.0100 for 100 x 50µL RT-qPCR reactions
M3164.0500 for 500 x 50µL RT-qPCR reactions

application:

Detection of SARS-CoV-2 Corona virus nucleocapsid fragment target N1 and the control target RNASeP according to the US Centers for Disease Control and Prevention (CDC)

Sicherheits Hinweise / Safety

Klassifizierungen / Classification

Dokumente - Protokolle - Downloads more

Dokumente - Protokolle - Downloads

Here you will find information and further literature on Genaxx1Step RT-qPCR SARS-CoV-2 Probe Kit. For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.

 
 
 
Dokumente - Protokolle - Downloads more

Dokumente - Protokolle - Downloads

The Genaxxo1Step SARS-CoV-2 Probe kit detects the new virus variant found to be responsible for a rapid increase in COVID-19 cases in South East England and defined by multiple spike protein mutations (deletion 69-70, deletion 144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H) as well as it does with the variant already known. Using the Genaxxon assay will make sure that this mutation will not be missed in testing patient samples on Corona.